3mL vial of Reta 5mg lyophilized powder.

Reta is an investigational once‑weekly injectable triple agonist (GIP, GLP‑1, and glucagon) for obesity, overweight, and metabolic disorders. It is not FDA‑approved and is only available in clinical trials.

Reta is the first-in-class triple hormone receptor agonist, activating:

GLP‑1 (reduces appetite, slows gastric emptying, improves insulin sensitivity)
GIP (enhances insulin secretion, affects lipid metabolism, reduces appetite)
Glucagon receptor (increases energy expenditure, promotes fat breakdown)

Materials

Details about the materials used in the product.

Shipping & Returns

Information about shipping and return policies.

Dimensions

Product dimensions and size information.

Care Instructions

Guidelines on how to take care of the product.

$159.99 USD

$85.99 USD